Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Surgical Wound Infection | 52 | 2024 | 1540 | 7.710 |
Why?
|
Hernia, Ventral | 19 | 2022 | 176 | 5.850 |
Why?
|
Surgical Mesh | 20 | 2022 | 276 | 5.770 |
Why?
|
Surgical Procedures, Operative | 52 | 2021 | 1877 | 4.910 |
Why?
|
Hospitals, Veterans | 44 | 2021 | 404 | 4.750 |
Why?
|
United States Department of Veterans Affairs | 37 | 2021 | 875 | 4.300 |
Why?
|
Antibiotic Prophylaxis | 19 | 2020 | 639 | 2.840 |
Why?
|
Hernia, Inguinal | 12 | 2020 | 210 | 2.630 |
Why?
|
Soft Tissue Infections | 7 | 2020 | 155 | 2.600 |
Why?
|
Postoperative Complications | 65 | 2021 | 15297 | 2.340 |
Why?
|
Ambulatory Surgical Procedures | 14 | 2021 | 455 | 2.290 |
Why?
|
Vancomycin | 15 | 2020 | 501 | 1.850 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 10 | 2021 | 687 | 1.840 |
Why?
|
Hernia, Abdominal | 5 | 2012 | 53 | 1.800 |
Why?
|
Anti-Infective Agents, Local | 6 | 2017 | 250 | 1.620 |
Why?
|
Quality Indicators, Health Care | 22 | 2018 | 1831 | 1.610 |
Why?
|
Colorectal Surgery | 7 | 2020 | 128 | 1.530 |
Why?
|
Oxazolidinones | 8 | 2012 | 96 | 1.500 |
Why?
|
Anti-Infective Agents | 8 | 2019 | 974 | 1.440 |
Why?
|
Biofilms | 4 | 2018 | 617 | 1.400 |
Why?
|
Acetamides | 8 | 2012 | 249 | 1.370 |
Why?
|
Patient Readmission | 17 | 2021 | 3116 | 1.270 |
Why?
|
Preoperative Care | 11 | 2020 | 2251 | 1.260 |
Why?
|
Digestive System Surgical Procedures | 7 | 2021 | 576 | 1.250 |
Why?
|
Staphylococcus aureus | 6 | 2018 | 1453 | 1.250 |
Why?
|
General Surgery | 14 | 2021 | 1636 | 1.250 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 2 | 2018 | 39 | 1.210 |
Why?
|
Appendiceal Neoplasms | 2 | 2019 | 146 | 1.200 |
Why?
|
Laparoscopy | 19 | 2016 | 2150 | 1.200 |
Why?
|
Antisepsis | 3 | 2016 | 18 | 1.190 |
Why?
|
Skin Diseases, Bacterial | 4 | 2014 | 66 | 1.180 |
Why?
|
Medical Errors | 14 | 2018 | 1297 | 1.120 |
Why?
|
Staphylococcal Infections | 9 | 2020 | 1400 | 1.030 |
Why?
|
Anti-Bacterial Agents | 25 | 2024 | 7182 | 0.950 |
Why?
|
Research Design | 14 | 2023 | 5984 | 0.950 |
Why?
|
Surgicenters | 2 | 2016 | 46 | 0.930 |
Why?
|
Quality Assurance, Health Care | 13 | 2021 | 2212 | 0.930 |
Why?
|
Veterans Health | 5 | 2021 | 216 | 0.910 |
Why?
|
Veterans | 14 | 2021 | 2519 | 0.910 |
Why?
|
Intraoperative Complications | 4 | 2018 | 1198 | 0.890 |
Why?
|
Safety Management | 11 | 2011 | 783 | 0.880 |
Why?
|
Appendicitis | 2 | 2019 | 645 | 0.850 |
Why?
|
Staphylococcal Skin Infections | 4 | 2012 | 75 | 0.830 |
Why?
|
beta-Lactams | 6 | 2017 | 160 | 0.820 |
Why?
|
Cefotetan | 5 | 2008 | 5 | 0.800 |
Why?
|
United States | 100 | 2024 | 69872 | 0.790 |
Why?
|
Negative-Pressure Wound Therapy | 2 | 2020 | 150 | 0.790 |
Why?
|
Cross Infection | 6 | 2018 | 1417 | 0.780 |
Why?
|
Abdominal Wall | 3 | 2019 | 157 | 0.770 |
Why?
|
Quality Improvement | 11 | 2021 | 3749 | 0.750 |
Why?
|
Length of Stay | 15 | 2021 | 6311 | 0.750 |
Why?
|
Guidelines as Topic | 6 | 2021 | 1405 | 0.740 |
Why?
|
Humans | 248 | 2024 | 744366 | 0.740 |
Why?
|
Benchmarking | 3 | 2022 | 1042 | 0.710 |
Why?
|
Cathartics | 3 | 2012 | 125 | 0.680 |
Why?
|
Operating Rooms | 4 | 2020 | 817 | 0.680 |
Why?
|
Foreign Medical Graduates | 2 | 2011 | 79 | 0.670 |
Why?
|
Perioperative Care | 6 | 2017 | 1002 | 0.660 |
Why?
|
Quality Control | 1 | 2021 | 841 | 0.650 |
Why?
|
Recurrence | 19 | 2022 | 8340 | 0.640 |
Why?
|
Research Report | 1 | 2021 | 355 | 0.630 |
Why?
|
Practice Guidelines as Topic | 11 | 2020 | 7282 | 0.620 |
Why?
|
Retrospective Studies | 75 | 2021 | 77460 | 0.600 |
Why?
|
Surgical Stomas | 1 | 2017 | 43 | 0.590 |
Why?
|
Disinfection | 2 | 2020 | 191 | 0.590 |
Why?
|
Abdominal Injuries | 1 | 2020 | 352 | 0.580 |
Why?
|
Ultrasonic Therapy | 1 | 2018 | 235 | 0.560 |
Why?
|
Surgery Department, Hospital | 2 | 2014 | 175 | 0.560 |
Why?
|
Infection Control | 7 | 2020 | 965 | 0.540 |
Why?
|
Device Removal | 1 | 2021 | 656 | 0.530 |
Why?
|
Consensus | 5 | 2022 | 2960 | 0.530 |
Why?
|
Urinary Tract Infections | 2 | 2020 | 788 | 0.510 |
Why?
|
Randomized Controlled Trials as Topic | 11 | 2021 | 9955 | 0.500 |
Why?
|
Delphi Technique | 7 | 2022 | 779 | 0.490 |
Why?
|
Colectomy | 4 | 2012 | 680 | 0.490 |
Why?
|
Male | 134 | 2024 | 350115 | 0.480 |
Why?
|
Medical Staff, Hospital | 2 | 2016 | 601 | 0.480 |
Why?
|
Clinical Trials as Topic | 6 | 2017 | 7914 | 0.480 |
Why?
|
Seroma | 3 | 2012 | 71 | 0.480 |
Why?
|
Risk Management | 1 | 2018 | 571 | 0.480 |
Why?
|
Middle Aged | 105 | 2021 | 213390 | 0.480 |
Why?
|
Personnel Staffing and Scheduling | 6 | 2020 | 500 | 0.470 |
Why?
|
Internship and Residency | 17 | 2020 | 5791 | 0.460 |
Why?
|
Postoperative Period | 4 | 2021 | 1842 | 0.460 |
Why?
|
Cholecystitis, Acute | 2 | 2012 | 70 | 0.460 |
Why?
|
Aged | 96 | 2021 | 163288 | 0.460 |
Why?
|
Treatment Outcome | 47 | 2023 | 63107 | 0.460 |
Why?
|
Colony Count, Microbial | 3 | 2018 | 331 | 0.450 |
Why?
|
Stents | 9 | 2017 | 3282 | 0.450 |
Why?
|
Clostridium Infections | 5 | 2019 | 548 | 0.450 |
Why?
|
Adrenergic beta-Antagonists | 4 | 2017 | 1240 | 0.430 |
Why?
|
International Cooperation | 3 | 2011 | 1420 | 0.430 |
Why?
|
Cholecystostomy | 1 | 2012 | 46 | 0.420 |
Why?
|
Guideline Adherence | 5 | 2019 | 2265 | 0.420 |
Why?
|
Validation Studies as Topic | 2 | 2017 | 159 | 0.420 |
Why?
|
Female | 125 | 2021 | 380193 | 0.420 |
Why?
|
Nasopharyngeal Diseases | 1 | 2011 | 25 | 0.420 |
Why?
|
Medically Underserved Area | 2 | 2011 | 253 | 0.400 |
Why?
|
Methicillin Resistance | 4 | 2006 | 198 | 0.400 |
Why?
|
Risk Factors | 54 | 2022 | 72296 | 0.390 |
Why?
|
History, 21st Century | 5 | 2017 | 1534 | 0.390 |
Why?
|
Urology | 1 | 2016 | 399 | 0.390 |
Why?
|
Incidence | 17 | 2021 | 20952 | 0.380 |
Why?
|
Acrospiroma | 1 | 2010 | 13 | 0.380 |
Why?
|
Iatrogenic Disease | 2 | 2011 | 547 | 0.380 |
Why?
|
Cholecystectomy | 2 | 2012 | 395 | 0.370 |
Why?
|
Clinical Competence | 9 | 2021 | 4687 | 0.370 |
Why?
|
Quality of Health Care | 10 | 2020 | 4369 | 0.360 |
Why?
|
Ethanol | 1 | 2016 | 1342 | 0.360 |
Why?
|
Critical Pathways | 1 | 2013 | 476 | 0.350 |
Why?
|
Cost-Benefit Analysis | 5 | 2020 | 5388 | 0.350 |
Why?
|
Pneumonia | 2 | 2020 | 2133 | 0.350 |
Why?
|
Hospitalization | 8 | 2022 | 10259 | 0.350 |
Why?
|
History, 20th Century | 6 | 2017 | 2740 | 0.350 |
Why?
|
Efficiency, Organizational | 2 | 2013 | 695 | 0.350 |
Why?
|
Clinical Coding | 9 | 2013 | 171 | 0.350 |
Why?
|
Patient Admission | 2 | 2016 | 1380 | 0.340 |
Why?
|
Gallbladder Diseases | 1 | 2010 | 125 | 0.340 |
Why?
|
Cholecystectomy, Laparoscopic | 2 | 2010 | 230 | 0.340 |
Why?
|
Sepsis | 3 | 2020 | 2593 | 0.340 |
Why?
|
Population Surveillance | 2 | 2010 | 2616 | 0.330 |
Why?
|
Communicable Diseases | 1 | 2017 | 880 | 0.330 |
Why?
|
Sweat Gland Neoplasms | 1 | 2010 | 108 | 0.330 |
Why?
|
Biomedical Research | 3 | 2017 | 3309 | 0.330 |
Why?
|
Cohort Studies | 25 | 2024 | 40559 | 0.330 |
Why?
|
Hernia, Umbilical | 2 | 2022 | 96 | 0.330 |
Why?
|
Nasal Mucosa | 1 | 2011 | 373 | 0.320 |
Why?
|
Rectal Diseases | 1 | 2009 | 143 | 0.310 |
Why?
|
Work Schedule Tolerance | 4 | 2020 | 563 | 0.310 |
Why?
|
Surgical Wound Dehiscence | 4 | 2013 | 215 | 0.310 |
Why?
|
Education, Medical, Graduate | 7 | 2020 | 2291 | 0.310 |
Why?
|
Colonic Diseases | 1 | 2009 | 202 | 0.310 |
Why?
|
Collagen | 3 | 2012 | 2688 | 0.300 |
Why?
|
Educational Measurement | 3 | 2007 | 1210 | 0.300 |
Why?
|
Acute Kidney Injury | 5 | 2019 | 1968 | 0.300 |
Why?
|
Arthroplasty, Replacement, Hip | 4 | 2019 | 1462 | 0.300 |
Why?
|
Logistic Models | 16 | 2019 | 13409 | 0.290 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2015 | 941 | 0.290 |
Why?
|
Comparative Effectiveness Research | 1 | 2012 | 680 | 0.290 |
Why?
|
Myocardial Revascularization | 6 | 2017 | 841 | 0.280 |
Why?
|
Faculty, Medical | 3 | 2016 | 1181 | 0.280 |
Why?
|
Arthroplasty, Replacement, Knee | 3 | 2019 | 1458 | 0.280 |
Why?
|
Workload | 5 | 2014 | 849 | 0.280 |
Why?
|
Time | 1 | 2008 | 542 | 0.270 |
Why?
|
Appendectomy | 2 | 2019 | 401 | 0.270 |
Why?
|
Skin | 3 | 2020 | 4372 | 0.270 |
Why?
|
Skin Diseases, Infectious | 1 | 2006 | 74 | 0.270 |
Why?
|
Methicillin | 1 | 2005 | 59 | 0.270 |
Why?
|
Abscess | 2 | 2019 | 607 | 0.260 |
Why?
|
Injections, Intravenous | 4 | 2016 | 1420 | 0.250 |
Why?
|
Ego | 1 | 2005 | 96 | 0.250 |
Why?
|
Postoperative Care | 4 | 2017 | 1487 | 0.250 |
Why?
|
Terminology as Topic | 3 | 2020 | 1547 | 0.250 |
Why?
|
Mortality | 1 | 2016 | 2864 | 0.250 |
Why?
|
Patient Care | 3 | 2009 | 640 | 0.250 |
Why?
|
Societies, Medical | 3 | 2020 | 3743 | 0.240 |
Why?
|
Bacterial Infections | 2 | 2010 | 1401 | 0.240 |
Why?
|
Vascular Surgical Procedures | 7 | 2017 | 1476 | 0.240 |
Why?
|
Biocompatible Materials | 1 | 2012 | 1736 | 0.230 |
Why?
|
Time Factors | 23 | 2020 | 40075 | 0.230 |
Why?
|
Diabetes Complications | 4 | 2016 | 1359 | 0.230 |
Why?
|
Mentors | 2 | 2021 | 631 | 0.230 |
Why?
|
Phosphates | 1 | 2007 | 785 | 0.220 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 1739 | 0.220 |
Why?
|
Follow-Up Studies | 14 | 2020 | 39052 | 0.220 |
Why?
|
Aged, 80 and over | 24 | 2021 | 57776 | 0.220 |
Why?
|
Leadership | 2 | 2020 | 1357 | 0.220 |
Why?
|
Protective Clothing | 2 | 2020 | 102 | 0.210 |
Why?
|
Wound Healing | 5 | 2020 | 2785 | 0.210 |
Why?
|
Administration, Oral | 5 | 2016 | 3914 | 0.210 |
Why?
|
United States Agency for Healthcare Research and Quality | 2 | 2012 | 92 | 0.210 |
Why?
|
Propensity Score | 4 | 2024 | 1781 | 0.210 |
Why?
|
Patient Care Team | 1 | 2013 | 2531 | 0.210 |
Why?
|
Risk Assessment | 15 | 2021 | 23336 | 0.210 |
Why?
|
Rectum | 4 | 2013 | 904 | 0.210 |
Why?
|
Risk Adjustment | 4 | 2015 | 594 | 0.200 |
Why?
|
Adult | 51 | 2021 | 214052 | 0.200 |
Why?
|
Streptococcal Infections | 1 | 2006 | 638 | 0.200 |
Why?
|
Predictive Value of Tests | 18 | 2017 | 15078 | 0.200 |
Why?
|
Hospital Mortality | 8 | 2020 | 5316 | 0.200 |
Why?
|
Polyethylene Glycols | 1 | 2007 | 1182 | 0.190 |
Why?
|
Informed Consent | 3 | 2014 | 995 | 0.190 |
Why?
|
Health Care Costs | 3 | 2010 | 3208 | 0.190 |
Why?
|
Medicare | 9 | 2021 | 6566 | 0.190 |
Why?
|
Patients | 3 | 2021 | 900 | 0.190 |
Why?
|
Patient Discharge | 6 | 2020 | 3318 | 0.190 |
Why?
|
False Positive Reactions | 9 | 2011 | 980 | 0.180 |
Why?
|
Health Services Research | 10 | 2011 | 1836 | 0.180 |
Why?
|
Multivariate Analysis | 10 | 2017 | 12244 | 0.180 |
Why?
|
Hysterectomy | 2 | 2018 | 927 | 0.180 |
Why?
|
Abdominal Cavity | 1 | 2020 | 52 | 0.180 |
Why?
|
Colon | 4 | 2013 | 1772 | 0.170 |
Why?
|
Abdominal Muscles | 1 | 2020 | 166 | 0.170 |
Why?
|
Chlorhexidine | 2 | 2011 | 162 | 0.170 |
Why?
|
Retirement | 1 | 2021 | 216 | 0.170 |
Why?
|
Prospective Studies | 16 | 2021 | 53290 | 0.170 |
Why?
|
Radionuclide Ventriculography | 1 | 1998 | 41 | 0.170 |
Why?
|
Drug Resistance, Microbial | 2 | 2017 | 862 | 0.170 |
Why?
|
Morbidity | 2 | 2018 | 1768 | 0.170 |
Why?
|
Professional Competence | 1 | 2002 | 447 | 0.170 |
Why?
|
Civil Defense | 1 | 2020 | 109 | 0.170 |
Why?
|
Thallium Radioisotopes | 1 | 1998 | 139 | 0.170 |
Why?
|
Cerebrovascular Disorders | 2 | 2017 | 1504 | 0.170 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3759 | 0.160 |
Why?
|
Patient Selection | 4 | 2016 | 4216 | 0.160 |
Why?
|
Dipyridamole | 1 | 1998 | 145 | 0.160 |
Why?
|
Abdomen | 2 | 2020 | 1118 | 0.160 |
Why?
|
Bacteriuria | 1 | 2019 | 102 | 0.160 |
Why?
|
Databases, Factual | 5 | 2018 | 7730 | 0.160 |
Why?
|
Decision Making | 1 | 2012 | 3888 | 0.160 |
Why?
|
Myocardial Infarction | 8 | 2017 | 11718 | 0.160 |
Why?
|
Pain, Postoperative | 2 | 2019 | 1643 | 0.160 |
Why?
|
Medical Records | 3 | 2020 | 1413 | 0.160 |
Why?
|
Sonication | 1 | 2018 | 83 | 0.150 |
Why?
|
Hospitals | 4 | 2019 | 3954 | 0.150 |
Why?
|
Bioprosthesis | 2 | 2012 | 597 | 0.150 |
Why?
|
Multicenter Studies as Topic | 2 | 2012 | 1677 | 0.150 |
Why?
|
Acute Disease | 4 | 2019 | 7147 | 0.150 |
Why?
|
Attitude of Health Personnel | 6 | 2016 | 3841 | 0.150 |
Why?
|
Hepatitis B, Chronic | 1 | 2021 | 393 | 0.150 |
Why?
|
Algorithms | 8 | 2020 | 13882 | 0.150 |
Why?
|
Comprehension | 2 | 2014 | 610 | 0.150 |
Why?
|
Chi-Square Distribution | 4 | 2012 | 3508 | 0.150 |
Why?
|
Operating Room Nursing | 1 | 2016 | 26 | 0.150 |
Why?
|
Anemia | 2 | 2017 | 1503 | 0.140 |
Why?
|
Liver Cirrhosis | 3 | 2022 | 1862 | 0.140 |
Why?
|
Angiography | 2 | 1993 | 1639 | 0.140 |
Why?
|
Abdominal Wound Closure Techniques | 1 | 2016 | 33 | 0.140 |
Why?
|
Societies, Scientific | 1 | 2017 | 220 | 0.140 |
Why?
|
Career Choice | 2 | 2016 | 744 | 0.140 |
Why?
|
Orbital Neoplasms | 1 | 1998 | 225 | 0.140 |
Why?
|
Vascular Diseases | 2 | 2009 | 1161 | 0.140 |
Why?
|
Common Bile Duct Diseases | 1 | 1995 | 37 | 0.140 |
Why?
|
Infusions, Intravenous | 3 | 2012 | 2274 | 0.140 |
Why?
|
Coronary Vessels | 3 | 2017 | 3107 | 0.140 |
Why?
|
Cholestasis, Extrahepatic | 1 | 1995 | 51 | 0.140 |
Why?
|
Pancreas | 2 | 1997 | 1687 | 0.140 |
Why?
|
Internal Medicine | 2 | 2014 | 1009 | 0.140 |
Why?
|
Survival Rate | 6 | 2021 | 12788 | 0.130 |
Why?
|
Obesity | 4 | 2017 | 12746 | 0.130 |
Why?
|
Orthopedic Procedures | 2 | 2024 | 1289 | 0.130 |
Why?
|
Gentamicins | 1 | 2016 | 255 | 0.130 |
Why?
|
Tissue Scaffolds | 2 | 2012 | 956 | 0.130 |
Why?
|
Drug-Eluting Stents | 4 | 2014 | 753 | 0.130 |
Why?
|
Proteinuria | 1 | 2018 | 658 | 0.130 |
Why?
|
Boston | 6 | 2018 | 9312 | 0.130 |
Why?
|
Orbit | 1 | 1998 | 426 | 0.130 |
Why?
|
End Stage Liver Disease | 1 | 2019 | 314 | 0.130 |
Why?
|
Community Health Services | 1 | 2020 | 650 | 0.130 |
Why?
|
Accreditation | 3 | 2014 | 452 | 0.130 |
Why?
|
Carrier State | 1 | 2018 | 518 | 0.130 |
Why?
|
Sutures | 1 | 2017 | 299 | 0.130 |
Why?
|
Odds Ratio | 6 | 2021 | 9849 | 0.120 |
Why?
|
Computer-Assisted Instruction | 1 | 2018 | 365 | 0.120 |
Why?
|
Medical Records Systems, Computerized | 8 | 2011 | 1205 | 0.120 |
Why?
|
Colorectal Neoplasms | 2 | 2007 | 6773 | 0.120 |
Why?
|
Blood Transfusion | 3 | 2017 | 1301 | 0.120 |
Why?
|
Disaster Planning | 1 | 2020 | 549 | 0.120 |
Why?
|
Checklist | 1 | 2021 | 833 | 0.120 |
Why?
|
Administration, Topical | 1 | 2016 | 690 | 0.120 |
Why?
|
World Health Organization | 1 | 2020 | 1318 | 0.120 |
Why?
|
Comorbidity | 5 | 2017 | 10388 | 0.120 |
Why?
|
Pulmonary Embolism | 3 | 2018 | 2375 | 0.120 |
Why?
|
Publishing | 1 | 2021 | 833 | 0.120 |
Why?
|
Inpatients | 8 | 2011 | 2518 | 0.120 |
Why?
|
History, 19th Century | 1 | 2016 | 720 | 0.120 |
Why?
|
Cardiovascular Diseases | 5 | 2016 | 15160 | 0.120 |
Why?
|
Duodenum | 2 | 1987 | 484 | 0.120 |
Why?
|
Problem-Based Learning | 1 | 1997 | 361 | 0.110 |
Why?
|
Respiratory Insufficiency | 2 | 2012 | 1199 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1487 | 0.110 |
Why?
|
Continuity of Patient Care | 3 | 2016 | 1049 | 0.110 |
Why?
|
Hospitals, Teaching | 3 | 2013 | 1180 | 0.110 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7658 | 0.110 |
Why?
|
Physician's Role | 1 | 2020 | 943 | 0.110 |
Why?
|
Cefazolin | 1 | 2013 | 96 | 0.110 |
Why?
|
Clinical Trials, Phase IV as Topic | 1 | 2012 | 27 | 0.110 |
Why?
|
Truth Disclosure | 1 | 2016 | 436 | 0.110 |
Why?
|
Patient Satisfaction | 4 | 2020 | 3395 | 0.110 |
Why?
|
Frail Elderly | 1 | 2017 | 693 | 0.110 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2017 | 3070 | 0.100 |
Why?
|
Reproducibility of Results | 12 | 2018 | 19905 | 0.100 |
Why?
|
Swine | 2 | 2012 | 5918 | 0.100 |
Why?
|
Military Medicine | 1 | 2014 | 176 | 0.100 |
Why?
|
Mass Screening | 3 | 2019 | 5253 | 0.100 |
Why?
|
Prostheses and Implants | 1 | 2019 | 1387 | 0.100 |
Why?
|
Biopsy, Needle | 1 | 1997 | 1641 | 0.100 |
Why?
|
Heart Arrest | 2 | 2014 | 1470 | 0.100 |
Why?
|
Demography | 1 | 2016 | 1655 | 0.100 |
Why?
|
Hypersensitivity | 1 | 2020 | 1102 | 0.100 |
Why?
|
Aneurysm, Infected | 1 | 2012 | 85 | 0.100 |
Why?
|
Program Evaluation | 2 | 2011 | 2488 | 0.100 |
Why?
|
Angina, Unstable | 1 | 2016 | 926 | 0.100 |
Why?
|
Pancreatic Neoplasms | 3 | 1999 | 5263 | 0.100 |
Why?
|
Multiple Trauma | 1 | 2014 | 367 | 0.100 |
Why?
|
Drug Therapy, Combination | 4 | 2017 | 6489 | 0.100 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2012 | 1186 | 0.100 |
Why?
|
Tissue Adhesions | 1 | 2012 | 235 | 0.100 |
Why?
|
Postoperative Hemorrhage | 2 | 2013 | 412 | 0.100 |
Why?
|
Venous Thrombosis | 2 | 2018 | 1239 | 0.090 |
Why?
|
Endpoint Determination | 1 | 2014 | 601 | 0.090 |
Why?
|
Preoperative Period | 3 | 2019 | 550 | 0.090 |
Why?
|
Blast Injuries | 1 | 2014 | 302 | 0.090 |
Why?
|
Poisson Distribution | 1 | 2011 | 513 | 0.090 |
Why?
|
Severity of Illness Index | 7 | 2019 | 15535 | 0.090 |
Why?
|
Quinolones | 1 | 2013 | 367 | 0.090 |
Why?
|
American Heart Association | 1 | 2014 | 1057 | 0.090 |
Why?
|
2-Propanol | 1 | 2010 | 28 | 0.090 |
Why?
|
Observer Variation | 6 | 2012 | 2593 | 0.090 |
Why?
|
Equipment Design | 1 | 2018 | 3582 | 0.090 |
Why?
|
Cystadenoma | 1 | 1990 | 84 | 0.090 |
Why?
|
Venous Thromboembolism | 2 | 2012 | 1671 | 0.090 |
Why?
|
Povidone-Iodine | 1 | 2010 | 59 | 0.090 |
Why?
|
Blood Loss, Surgical | 2 | 2013 | 662 | 0.090 |
Why?
|
Communication | 2 | 2016 | 3750 | 0.090 |
Why?
|
Cross-Sectional Studies | 11 | 2015 | 25039 | 0.090 |
Why?
|
Probability | 4 | 2008 | 2506 | 0.090 |
Why?
|
Hematoma | 2 | 2012 | 758 | 0.090 |
Why?
|
Health Personnel | 1 | 2023 | 3219 | 0.090 |
Why?
|
Arteries | 2 | 1998 | 1119 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2000 | 2949 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2018 | 1771 | 0.080 |
Why?
|
Delivery of Health Care | 3 | 2020 | 5321 | 0.080 |
Why?
|
Ultrasonography | 2 | 2019 | 5984 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1170 | 0.080 |
Why?
|
Health Facility Environment | 1 | 2009 | 34 | 0.080 |
Why?
|
Treatment Failure | 3 | 2016 | 2618 | 0.080 |
Why?
|
Hyperglycemia | 1 | 2017 | 1373 | 0.080 |
Why?
|
Case-Control Studies | 4 | 2016 | 21748 | 0.080 |
Why?
|
Pancreatitis | 1 | 1995 | 1092 | 0.080 |
Why?
|
Pulmonary Atelectasis | 1 | 2009 | 145 | 0.080 |
Why?
|
Analysis of Variance | 5 | 2010 | 6366 | 0.080 |
Why?
|
Data Mining | 1 | 2013 | 537 | 0.080 |
Why?
|
Emotions | 1 | 2020 | 2659 | 0.080 |
Why?
|
Survival Analysis | 3 | 2011 | 10252 | 0.080 |
Why?
|
Review Literature as Topic | 1 | 2010 | 336 | 0.080 |
Why?
|
Abdominal Abscess | 1 | 2009 | 154 | 0.080 |
Why?
|
Gangrene | 2 | 2004 | 82 | 0.080 |
Why?
|
Income | 1 | 2016 | 1913 | 0.080 |
Why?
|
Ascites | 2 | 2022 | 344 | 0.080 |
Why?
|
Extremities | 1 | 1993 | 866 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2013 | 867 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 1 | 2000 | 4554 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2000 | 3707 | 0.070 |
Why?
|
California | 1 | 2011 | 1402 | 0.070 |
Why?
|
Retreatment | 1 | 2009 | 610 | 0.070 |
Why?
|
Perception | 3 | 2021 | 1198 | 0.070 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 642 | 0.070 |
Why?
|
Specialties, Surgical | 2 | 2013 | 391 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2017 | 2158 | 0.070 |
Why?
|
Aztreonam | 1 | 2006 | 12 | 0.070 |
Why?
|
Foreign Bodies | 1 | 2011 | 400 | 0.070 |
Why?
|
Israel | 1 | 2009 | 796 | 0.070 |
Why?
|
Databases as Topic | 1 | 2009 | 475 | 0.070 |
Why?
|
Penicillanic Acid | 1 | 2006 | 45 | 0.070 |
Why?
|
Cattle | 1 | 2012 | 3922 | 0.070 |
Why?
|
Digestive System Neoplasms | 1 | 1986 | 86 | 0.070 |
Why?
|
Catheterization, Central Venous | 1 | 2011 | 514 | 0.070 |
Why?
|
Blood Vessels | 1 | 1992 | 1125 | 0.070 |
Why?
|
Pneumoperitoneum | 2 | 1997 | 46 | 0.070 |
Why?
|
Americas | 1 | 2005 | 111 | 0.070 |
Why?
|
Advisory Committees | 1 | 2010 | 775 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1722 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1584 | 0.070 |
Why?
|
Bacteria | 1 | 2016 | 2115 | 0.070 |
Why?
|
Carcinoma | 1 | 1997 | 2375 | 0.070 |
Why?
|
Coronary Angiography | 2 | 2016 | 4576 | 0.070 |
Why?
|
Focus Groups | 1 | 2010 | 1321 | 0.070 |
Why?
|
Evidence-Based Medicine | 2 | 2019 | 3611 | 0.060 |
Why?
|
Anesthesia | 1 | 2016 | 1561 | 0.060 |
Why?
|
Pain Measurement | 2 | 2017 | 3420 | 0.060 |
Why?
|
Military Personnel | 1 | 2014 | 1133 | 0.060 |
Why?
|
Gastric Emptying | 1 | 1987 | 233 | 0.060 |
Why?
|
Activities of Daily Living | 2 | 2012 | 2419 | 0.060 |
Why?
|
New Zealand | 1 | 2005 | 355 | 0.060 |
Why?
|
Jejunum | 1 | 1987 | 480 | 0.060 |
Why?
|
Sex Factors | 2 | 2009 | 10400 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1741 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3020 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2000 | 5856 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2010 | 970 | 0.060 |
Why?
|
Bile Duct Neoplasms | 1 | 1990 | 567 | 0.060 |
Why?
|
Schools, Medical | 1 | 2011 | 881 | 0.060 |
Why?
|
Sensitivity and Specificity | 6 | 2018 | 14723 | 0.060 |
Why?
|
Heart Diseases | 1 | 2017 | 2789 | 0.060 |
Why?
|
Linear Models | 2 | 2011 | 5953 | 0.060 |
Why?
|
Asia | 1 | 2005 | 609 | 0.060 |
Why?
|
Leg Ulcer | 1 | 2004 | 69 | 0.060 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2003 | 30 | 0.060 |
Why?
|
Awards and Prizes | 1 | 2008 | 375 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8319 | 0.060 |
Why?
|
Adolescent | 10 | 2010 | 85779 | 0.060 |
Why?
|
Ethics, Clinical | 1 | 2004 | 101 | 0.060 |
Why?
|
Penicillins | 1 | 2006 | 380 | 0.060 |
Why?
|
Meta-Analysis as Topic | 1 | 2008 | 1342 | 0.060 |
Why?
|
Anticoagulants | 3 | 2017 | 4600 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1999 | 4034 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3922 | 0.060 |
Why?
|
Emergency Treatment | 1 | 2007 | 517 | 0.060 |
Why?
|
Adenocarcinoma | 2 | 2000 | 6364 | 0.060 |
Why?
|
Coronary Disease | 2 | 2016 | 6077 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5135 | 0.060 |
Why?
|
Cholecystitis | 1 | 2003 | 182 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 4 | 2019 | 20130 | 0.050 |
Why?
|
Health Services Needs and Demand | 1 | 2011 | 1410 | 0.050 |
Why?
|
Intestinal Diseases | 1 | 2007 | 530 | 0.050 |
Why?
|
Foot Diseases | 1 | 2003 | 143 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3677 | 0.050 |
Why?
|
Drug Combinations | 3 | 2017 | 1958 | 0.050 |
Why?
|
Medicaid | 1 | 2015 | 2737 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3255 | 0.050 |
Why?
|
Gallbladder | 1 | 2003 | 302 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9584 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2009 | 4933 | 0.050 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2009 | 1131 | 0.050 |
Why?
|
Safety | 2 | 2007 | 1186 | 0.050 |
Why?
|
Urinalysis | 1 | 2024 | 369 | 0.050 |
Why?
|
False Negative Reactions | 2 | 2013 | 588 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 1993 | 1917 | 0.050 |
Why?
|
Body Mass Index | 2 | 2010 | 12721 | 0.050 |
Why?
|
Confidence Intervals | 3 | 2014 | 2971 | 0.050 |
Why?
|
Reference Values | 1 | 2008 | 4982 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2016 | 12025 | 0.050 |
Why?
|
Personal Satisfaction | 1 | 2005 | 643 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.050 |
Why?
|
Lacerations | 2 | 2012 | 144 | 0.050 |
Why?
|
Health Services Administration | 1 | 2020 | 64 | 0.040 |
Why?
|
Role | 1 | 2020 | 175 | 0.040 |
Why?
|
Coronary Artery Disease | 3 | 2016 | 6486 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6896 | 0.040 |
Why?
|
Epidemiologic Methods | 1 | 2004 | 1364 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2010 | 8642 | 0.040 |
Why?
|
Likelihood Functions | 2 | 2013 | 1005 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2021 | 438 | 0.040 |
Why?
|
Europe | 1 | 2005 | 3338 | 0.040 |
Why?
|
Medical Audit | 2 | 2012 | 467 | 0.040 |
Why?
|
Prognosis | 5 | 2019 | 29060 | 0.040 |
Why?
|
Budgets | 1 | 2020 | 229 | 0.040 |
Why?
|
Medication Reconciliation | 1 | 2020 | 151 | 0.040 |
Why?
|
Liver Neoplasms | 2 | 1995 | 4253 | 0.040 |
Why?
|
Drug Costs | 1 | 2006 | 1105 | 0.040 |
Why?
|
Single-Blind Method | 2 | 2016 | 1590 | 0.040 |
Why?
|
Equipment and Supplies | 1 | 2020 | 281 | 0.040 |
Why?
|
Animals | 5 | 2012 | 168768 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2000 | 381 | 0.040 |
Why?
|
Electronic Health Records | 4 | 2017 | 4468 | 0.040 |
Why?
|
Age Factors | 3 | 2010 | 18373 | 0.040 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 1997 | 83 | 0.040 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2019 | 264 | 0.040 |
Why?
|
Lacrimal Apparatus | 1 | 1998 | 225 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12356 | 0.040 |
Why?
|
Regression Analysis | 1 | 2006 | 6459 | 0.030 |
Why?
|
Stomach Diseases | 1 | 1997 | 134 | 0.030 |
Why?
|
Physicians | 2 | 2005 | 4567 | 0.030 |
Why?
|
Injections, Intra-Articular | 1 | 2017 | 278 | 0.030 |
Why?
|
Socioeconomic Factors | 3 | 2017 | 7785 | 0.030 |
Why?
|
Gels | 1 | 2016 | 427 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3799 | 0.030 |
Why?
|
Reimbursement Mechanisms | 2 | 2014 | 670 | 0.030 |
Why?
|
Telemedicine | 2 | 2020 | 2872 | 0.030 |
Why?
|
Infusion Pumps, Implantable | 1 | 1995 | 156 | 0.030 |
Why?
|
Coloring Agents | 1 | 1997 | 566 | 0.030 |
Why?
|
Hospital Costs | 2 | 2014 | 985 | 0.030 |
Why?
|
Glucose | 1 | 1987 | 4398 | 0.030 |
Why?
|
Stroke | 3 | 2017 | 9981 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 12802 | 0.030 |
Why?
|
Fatal Outcome | 3 | 2012 | 1851 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2021 | 2539 | 0.030 |
Why?
|
Hematocrit | 1 | 2016 | 636 | 0.030 |
Why?
|
Afghanistan | 1 | 2014 | 81 | 0.030 |
Why?
|
Helicobacter pylori | 1 | 1997 | 383 | 0.030 |
Why?
|
Helicobacter Infections | 1 | 1997 | 387 | 0.030 |
Why?
|
Cause of Death | 1 | 2004 | 3582 | 0.030 |
Why?
|
Models, Statistical | 4 | 2014 | 5101 | 0.030 |
Why?
|
Hospital Records | 1 | 2013 | 95 | 0.030 |
Why?
|
Diatrizoate Meglumine | 1 | 1993 | 83 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 1997 | 435 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18034 | 0.030 |
Why?
|
Arthroplasty, Replacement | 1 | 2017 | 339 | 0.030 |
Why?
|
Time and Motion Studies | 1 | 2013 | 149 | 0.030 |
Why?
|
Neomycin | 1 | 2012 | 88 | 0.030 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1995 | 504 | 0.030 |
Why?
|
Afghan Campaign 2001- | 1 | 2014 | 272 | 0.030 |
Why?
|
Qualitative Research | 1 | 2021 | 2682 | 0.030 |
Why?
|
Video Recording | 1 | 2018 | 949 | 0.030 |
Why?
|
Erythromycin | 1 | 2012 | 120 | 0.030 |
Why?
|
Sentinel Surveillance | 1 | 2014 | 281 | 0.030 |
Why?
|
Feces | 1 | 2018 | 1401 | 0.030 |
Why?
|
Thoracotomy | 1 | 1994 | 363 | 0.030 |
Why?
|
Health Care Reform | 2 | 2014 | 1261 | 0.030 |
Why?
|
Insulin | 1 | 1987 | 6582 | 0.030 |
Why?
|
Specialty Boards | 1 | 2014 | 227 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 1997 | 1094 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 1995 | 403 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 1995 | 1107 | 0.030 |
Why?
|
Health Care Surveys | 2 | 2013 | 2453 | 0.030 |
Why?
|
Thoracic Injuries | 1 | 1994 | 272 | 0.030 |
Why?
|
Drainage | 1 | 2017 | 1142 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6171 | 0.030 |
Why?
|
Accidents | 1 | 2012 | 164 | 0.020 |
Why?
|
Metronidazole | 1 | 2012 | 217 | 0.020 |
Why?
|
Fungemia | 1 | 2011 | 53 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2951 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2013 | 502 | 0.020 |
Why?
|
Risk | 2 | 2013 | 9688 | 0.020 |
Why?
|
Stomach Neoplasms | 2 | 1997 | 1332 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2166 | 0.020 |
Why?
|
Triage | 1 | 2017 | 977 | 0.020 |
Why?
|
Aortography | 1 | 2012 | 437 | 0.020 |
Why?
|
Physician-Patient Relations | 2 | 2016 | 3229 | 0.020 |
Why?
|
Wounds, Penetrating | 1 | 2012 | 307 | 0.020 |
Why?
|
Ileum | 1 | 2012 | 565 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 6539 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1438 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 1997 | 1095 | 0.020 |
Why?
|
Home Care Services | 1 | 2016 | 606 | 0.020 |
Why?
|
Coronary Thrombosis | 1 | 2013 | 495 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2017 | 1372 | 0.020 |
Why?
|
Wounds and Injuries | 2 | 2010 | 2400 | 0.020 |
Why?
|
Curriculum | 1 | 2002 | 3605 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 1997 | 1364 | 0.020 |
Why?
|
Lung Injury | 1 | 1994 | 436 | 0.020 |
Why?
|
Adenoma | 1 | 2000 | 2174 | 0.020 |
Why?
|
Blood Coagulation Factors | 1 | 2011 | 355 | 0.020 |
Why?
|
Nose | 1 | 2012 | 509 | 0.020 |
Why?
|
Blood Glucose | 2 | 2017 | 6254 | 0.020 |
Why?
|
Autopsy | 1 | 2012 | 1020 | 0.020 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2009 | 194 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1856 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2018 | 2050 | 0.020 |
Why?
|
Wounds, Gunshot | 1 | 1994 | 563 | 0.020 |
Why?
|
Mental Recall | 1 | 2014 | 1206 | 0.020 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1987 | 43 | 0.020 |
Why?
|
Patients' Rooms | 1 | 2007 | 63 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2716 | 0.020 |
Why?
|
Pneumothorax | 1 | 2010 | 379 | 0.020 |
Why?
|
Adenoma, Islet Cell | 1 | 1986 | 82 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2011 | 465 | 0.020 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2012 | 1391 | 0.020 |
Why?
|
Pyloric Antrum | 1 | 1986 | 69 | 0.020 |
Why?
|
Diabetic Foot | 1 | 2010 | 355 | 0.020 |
Why?
|
Personnel, Hospital | 1 | 2009 | 283 | 0.020 |
Why?
|
Pylorus | 1 | 1986 | 86 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2009 | 977 | 0.020 |
Why?
|
Duodenal Neoplasms | 1 | 1986 | 106 | 0.020 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1986 | 111 | 0.020 |
Why?
|
Methods | 1 | 1986 | 1129 | 0.020 |
Why?
|
Poverty | 1 | 2018 | 2660 | 0.020 |
Why?
|
Ampulla of Vater | 1 | 1986 | 141 | 0.020 |
Why?
|
Hernia | 1 | 2006 | 71 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2000 | 11366 | 0.020 |
Why?
|
APACHE | 1 | 2006 | 277 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2278 | 0.020 |
Why?
|
Splenectomy | 1 | 1987 | 395 | 0.020 |
Why?
|
Oxygen | 1 | 2017 | 4189 | 0.020 |
Why?
|
Internet | 1 | 2018 | 3056 | 0.020 |
Why?
|
Serum Albumin | 1 | 2008 | 675 | 0.020 |
Why?
|
Hospitals, University | 1 | 2007 | 570 | 0.020 |
Why?
|
Endarterectomy, Carotid | 1 | 2010 | 546 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2008 | 987 | 0.020 |
Why?
|
Hemorrhage | 1 | 2017 | 3461 | 0.020 |
Why?
|
Students, Medical | 1 | 2018 | 1862 | 0.020 |
Why?
|
Sulbactam | 1 | 2003 | 26 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4153 | 0.020 |
Why?
|
Bacteremia | 1 | 2011 | 963 | 0.010 |
Why?
|
Glucose Tolerance Test | 1 | 1987 | 1151 | 0.010 |
Why?
|
Ampicillin | 1 | 2003 | 139 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1998 | 12961 | 0.010 |
Why?
|
Medication Adherence | 1 | 2014 | 2063 | 0.010 |
Why?
|
Rehabilitation | 1 | 2004 | 134 | 0.010 |
Why?
|
Anesthesiology | 1 | 2013 | 1060 | 0.010 |
Why?
|
Random Allocation | 1 | 1987 | 2428 | 0.010 |
Why?
|
Leiomyosarcoma | 1 | 1986 | 477 | 0.010 |
Why?
|
Educational Status | 1 | 2010 | 2540 | 0.010 |
Why?
|
Dogs | 1 | 1987 | 3912 | 0.010 |
Why?
|
Cardiology | 1 | 2013 | 1668 | 0.010 |
Why?
|
Prostatectomy | 1 | 2010 | 1890 | 0.010 |
Why?
|
Chronic Disease | 1 | 1995 | 9145 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3339 | 0.010 |
Why?
|
Fellowships and Scholarships | 1 | 2008 | 1078 | 0.010 |
Why?
|
Child, Preschool | 2 | 1993 | 41005 | 0.010 |
Why?
|
Quality-Adjusted Life Years | 1 | 2006 | 1683 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 56429 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2003 | 1588 | 0.010 |
Why?
|
Psychometrics | 1 | 2009 | 3003 | 0.010 |
Why?
|
Internationality | 1 | 2005 | 1002 | 0.010 |
Why?
|
Sex Distribution | 1 | 2004 | 2297 | 0.010 |
Why?
|
Death | 1 | 2004 | 678 | 0.010 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 1998 | 33 | 0.010 |
Why?
|
Leg | 1 | 2004 | 1116 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2004 | 1877 | 0.010 |
Why?
|
Age Distribution | 1 | 2004 | 2902 | 0.010 |
Why?
|
Alcian Blue | 1 | 1997 | 13 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2013 | 3537 | 0.010 |
Why?
|
Health Services | 1 | 2003 | 758 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2003 | 1680 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 1997 | 354 | 0.010 |
Why?
|
ROC Curve | 1 | 2004 | 3528 | 0.010 |
Why?
|
Epirubicin | 1 | 1995 | 80 | 0.010 |
Why?
|
Child | 3 | 1993 | 77709 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13286 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1987 | 2134 | 0.010 |
Why?
|
Lung | 1 | 1994 | 9857 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 1995 | 234 | 0.010 |
Why?
|
Mitomycin | 1 | 1995 | 259 | 0.010 |
Why?
|
Insurance, Health | 1 | 2007 | 2494 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1995 | 11525 | 0.010 |
Why?
|
Hepatic Artery | 1 | 1995 | 245 | 0.010 |
Why?
|
Hemothorax | 1 | 1994 | 60 | 0.010 |
Why?
|
Angina Pectoris | 1 | 1998 | 977 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2007 | 3680 | 0.010 |
Why?
|
Veins | 1 | 1998 | 770 | 0.010 |
Why?
|
Microcirculation | 1 | 1998 | 1287 | 0.010 |
Why?
|
Health Surveys | 1 | 2003 | 4036 | 0.010 |
Why?
|
Mice | 1 | 2000 | 81201 | 0.010 |
Why?
|
Coronary Circulation | 1 | 1998 | 1572 | 0.010 |
Why?
|
Laser Therapy | 1 | 1998 | 1072 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 10943 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 1998 | 35425 | 0.010 |
Why?
|
Emergencies | 1 | 1997 | 1170 | 0.010 |
Why?
|
Fluorouracil | 1 | 1995 | 1619 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 1998 | 2288 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 1998 | 2148 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 2003 | 5749 | 0.000 |
Why?
|
Platelet Count | 1 | 1987 | 780 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1995 | 2542 | 0.000 |
Why?
|
Autoantibodies | 1 | 1987 | 2036 | 0.000 |
Why?
|
Reoperation | 1 | 1987 | 4201 | 0.000 |
Why?
|
Cell Survival | 1 | 1987 | 5882 | 0.000 |
Why?
|
Blood Platelets | 1 | 1987 | 2509 | 0.000 |
Why?
|